TY  - RPRT
TI  - Drug-gene interaction screens coupled to tumour data analyses identify the most clinically-relevant cancer vulnerabilities driving sensitivity to PARP inhibition
AU  - Jamal, K.
AU  - Galbiati, A.
AU  - Armenia, J.
AU  - Illuzzi, G.
AU  - Hall, J.
AU  - Bentouati, S.
AU  - Barrell, D.
AU  - Ahdesmäki, M.
AU  - Functional Genomics Centre,
AU  - O'Connor, M. J.
AU  - Leo, E.
AU  - Forment, J. V.
PY  - 2022
DO  - 10.1101/2022.07.29.501846
UR  - https://www.biorxiv.org/content/10.1101/2022.07.29.501846v1
ID  - 10.1101/2022.07.29.501846
ER  -